Investigating the hedonic effects of interferon-α on female rats using brain-stimulation reward

Behavioural Brain Research

Volumn 177, Issue 1, 2007, Pages 90-99

  Kentner, Amanda C ^a   James, Jonathan S ^a   Miguelez, Maïa ^a   Bielajew, Catherine ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anhedonia; Brain stimulation reward; Cytokine; Locomotor activity; Piloerection; Sickness behaviour; Temperature; Ventral tegmental area

Indexed keywords

ALPHA INTERFERON; CYTOKINE; RECOMBINANT ALPHA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; BRAIN DEPTH STIMULATION; CANCER THERAPY; CONTROLLED STUDY; DEPRESSION; FEMALE; FOOD INTAKE; ILLNESS BEHAVIOR; LOCOMOTION; LONG EVANS RAT; NONHUMAN; PRIORITY JOURNAL; RAT; REFLEX; TEMPERATURE; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL RESPONSE MODIFIERS; BRAIN; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; FEMALE; INTERFERON-ALPHA; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; REWARD; SELF STIMULATION;

EID: 33845974906     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.10.033     Document Type: Article

References (77)

1. Andrews G., Issakidis C., and Carter G. Shortfall in mental health service utilization. Brit J Psychiatry 179 (2001) 417-425
2. Anisman H., Kokkinidis L., Borowski T., and Merali Z. Differential effects of interleukin (IL)-1β, IL-2 and IL-6 on responding for lateral hypothalamic stimulation. Brain Res 779 (1998) 177-187
3. Anisman H., Kokkinidis L., and Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res 731 (1996) 1-11
4. Anisman H., Zalcman S., and Zacharko R.M. The impact of stressors on immune and central neurotransmitter activity: bidirectional communication. Rev Neurosci 4 (1993) 147-180
5. Auriacombe M., Reneric J.P., and Le Moal M. Animal models of anhedonia. Psychopharmacology 134 (1997) 337-338
6. Avitsur R., and Yirmiya R. Cytokines inhibit sexual behavior in female rats. I. Synergistic effects of tumor necrosis factor alpha and interleukin-1. Brain Behav Immun 13 (1999) 14-32
7. Baker S.L., Kentner A.C., Konkle A.T., Santa-Maria Barbagallo L., and Bielajew C. Behavioral and physiological effects of chronic mild stress in female rats. Physiol Behav 87 (2006) 314-322
8. Barsky A.J., Peekna H.M., and Borus J.F. Somatic symptom reporting in women and men. J Gen Intern Med 16 (2001) 266-275
9. Bethus I., Stinus L., and Goodall G. Chronic interferon-α potentiates latent inhibition in rats. Behav Brain Res 144 (2003) 167-174
10. Bielajew C., Konkle A.T., Kentner A.C., Baker S.L., Stewart A., Hutchins A.A., et al. Strain and gender specific effects in the forced swim test: effects of previous stress exposure. Stress 6 (2003) 269-280
11. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 69 (1989) 1-32
12. Blatteis C.M., Xin L., and Quan N. Neuromodulation of fever: apparent involvement of opiods. Brain Res Bull 26 (1991) 219-223
13. Bowman R.E., Beck K.D., and Luine V.N. Chronic stress effects on memory: sex differences in performance and monoaminergic activity. Horm Behav 43 (2003) 48-59
14. Brebner K., Hayley S., Zacharko R., Merali Z., and Anisman H. Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α: central monamine, corticosterone, and behavioral variations. Neuropsychopharmacology 22 (2000) 566-580
15. Capuron L., Ravaud A., and Dantzer R. Early depressive symptoms in cancer patients receiving IL-2 and/or IFN-alfa-2b therapy. J Clin Oncol 18 (2000) 2143-2151
16. Crnic L.S., and Segall M. Behavioral effects of mouse interferons-α and -γ and human interferon-α in mice. Brain Res 590 (1992) 277-284
17. Collier J., and Chapman R. Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues. Biodrugs 15 (2001) 225-238
18. Cotton S.M., Wright A., Harris M.G., Jorm A.F., and McGorry P.D. Influence of gender on mental health literacy in young Australians. Aust N Z J Psychiatry 40 (2006) 790-796
19. Dalla C., Antoniou K., Drossopoulou G., Xagoraris M., Kokras N., Sfikakis A., et al. Chronic mild stress impact: are females more vulnerable?. Neuroscience 135 (2005) 703-714
20. De La Garza II R., Asnis G.M., Fabrizio K.R., and Pedrosa E. Acute diclofenac treatment attenuates lipopolysaccharide-induced alterations to basic reward behavior and HPA axis activation in rats. Psychopharmacology 179 (2005) 356-365
21. De La Garza II R., Asnis G.M., Pedrosa E., Stearns C., Migdal A.L., Reinus J.F., et al. Recombinant human interferon-α does not alter reward behavior or neuroimmune and neuroendocrine activation in rats. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 781b-792b
22. Dinarello C.A., Bernheim H.A., Duff G.W., Le H.V., Nagabhushan T.L., Hamilton N.C., et al. Mechanisms of fever induced by recombinant human interferon. J Clin Invest 74 (1984) 906-913
23. Drossopoulou G., Antoniou K., Kitraki E., Papathanasiou G., Papalexi E., Dalla C., et al. Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126 (2004) 849-857
24. Duncko R., Kiss A., Skultetyova I., Rusnak M., and Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 26 (2001) 77-89
25. Dunn A.J. Interleukin-1 acts as a stimulator of hormone secretion. Prog Neurol Endocrinol Immunol 3 (1990) 26-34
26. Gater R.A., Dean C., and Morris J. The contribution of childbearing to the sex difference in first admission rates for affective psychosis. Psychol Med 19 (1989) 719-724
27. Gutiérrez-Lobos K., Scherer M., Anderer P., and Katschnig H. The influence of age on the female/male ratio of treated incidence rates in depression. BMC Psychiatry 2 (2002) 3-10
28. Hankin B.L., and Abramson L.Y. Development of gender differences in depression: description and possible explanations. Finnish Ann Med 31 (1999) 372-379
29. Hart B.L. Biological basis of the behaviour of sick animals. Neurosci Biobehav Rev 12 (1988) 123-127
30. Hayley S., Brebner, Lacosta S., Merali Z., and Anisman H. Sensitization to the effects of tumor necrosis factor-α: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 19 (1999) 5654-5665
31. Hayley S., Kelly O., and Anisman H. Murine tumor necrosis factor-α sensitized plasma corticosterone activity and the manifestation of shock: modulation by histamine. J Neuroimmunol 131 (2002) 60-69
32. Hebb A.L.O., Zacharko R.M., and Anisman H. Self-stimulation from the mesencephalon following intraventricular interleukin-2 administration. Brain Res Bull 45 (1998) 549-556
33. Howell D.C. Statistical methods for psychology. 5th ed. (2002), Duxbury Press, Belmont, Canada
34. Janicki P.K. Binding of human alpha-interferon in the brain tissue membranes of the rat. Res Commun Chem Path Pharmacol 75 (1992) 117-120
35. Jorm A.F. Sex and age differences in depression. A quantitative synthesis of published research. Aust N Z Psychiatry 21 (1987) 46-53
36. Karandrea D., Kittas C., and Kitraki E. Forced swimming differentially affects male and female brain corticosteroid receptors. Neuroendocrinology 75 (2002) 217-226
37. Katz R. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 16 (1982) 965-968
38. Kent S., Bluthé R.-M., Kelley K.W., and Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13 (1992) 24-28
39. Kentner A.C., Miguelez M., James J.S., and Bielajew C. Behavioral and physiological effects of a single injection of rat interferon-α on male Sprague-Dawley rats: a long-term evaluation. Brain Res 1095 (2006) 96-106
40. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., and Nelson C.B. Sex and depression in the National Comorbidity Survey. I. Lifetime prevalence, chronicity, and recurrence. J Affect Dis 29 (1993) 85-96
41. Konkle A.T.M., Baker S.L., Kentner A.C., Barbagallo L.S., Merali Z., and Bielajew C. Evaluation of the effects of chronic mild stressors on hedonic and physiological responses: sex and strain compared. Brain Res 992 (2003) 227-238
42. Kornstein S.G. Gender differences in depression: implications for treatment. J Clin Psychiatry 58 (1997) 12-18
43. Kumai T., Tateishi T., Tanaka M., Watananbe M., Shimizu H., and Kobayashi S. Effect of interferon-α on tyrosine hydroxylase and catecholamine levels in the brain of rats. Life Sci 67 (2000) 663-669
44. Larson S.J., and Dunn A.J. Behavioral effects of cytokines. Brain Behav Immun 15 (2001) 371-387
45. Loftis J.M., and Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Dis 82 (2004) 175-190
46. Lucht M., Schaub R.T., Meyer C., Hapke U., Rumpf H.J., Bartels T., et al. Gender differences in unipolar depression: a general population survey of adults between age 18 and 64 of German nationality. J Affect Dis 77 (2003) 203-211
47. Maes M., Capuron L., Ravaud A., Gualde N., Bosmans E., Egyed B., et al. Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy. Neuropsychopharmacology 24 (2001) 130-140
48. Makino M., Kitano Y., Komiyama C., and Takasuna K. Human interferon-α increases immobility in the forced swimming test in rats. Psychopharmacology 148 (2000) 106-110
49. Makino M., Kitano Y., Hirohashi M., and Takasuna K. Enhancement of immobility in mouse forced swimming test by treatment with human interferon. Eur J Pharmacol 356 (1998) 1-7
50. Miguelez M., Lacasse M., Kentner A.C., Rizk I., Fouriezos G., and Bielajew C. Short- and long-term effects of Interleukin-2 on weight, food intake, and hedonic mechanisms in the rat. Behav Brain Res 154 (2004) 311-319
51. Merali Z., Levac C., and Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 54 5 (2003) 552-565
52. Moreau J.-L., Borgulya J., Jenck F., and Martin J.R. Tolcapone: a potential new antidepressant detected in a novel animal model of depression. Behav Pharmacol 5 (1994) 344-350
53. Moreau J.-L., Bös M., Jenck F., Martin J.R., Mortas P., and Wichmann J. 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6 (1996) 169-175
54. Moreau J.-L., Bourson A., Jenck F., Martin J.R., and Mortas P. Curative effects of the atypical antidepressant Mianserin in the chronic mild stress-induced anhedonia model of depression. J Psychiatry Neurosci 19 (1993) 51-56
55. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344 (2001) 961-966
56. Oitzl M.S., van Oers H., Schöbitz B., and de Kloet E.R. Interleukin-1β, but not interleukin-6 impairs spatial navigation learning. Brain Res 613 (1993) 160-163
57. Palanza P. Animal model of anxiety and depression: how are females different?. Neurosci Biobehav Rev 25 (2001) 219-233
58. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1998), Academic Press, Sydney
59. Pestka S., Langer J.A., Zoon K.C., and Samuel C.E. Interferons and their actions. Ann Rev Biochem 56 (1987) 727-777
60. Plata-Salamàn C.R. Cytokine-induced anorexia. Behavioral, cellular, and molecular mechanisms. Ann NY Acad Sci 856 (1998) 160-170
61. Reyes-Vazquez C., Prieto-Gomez B., and Dafny N. Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus. Neuropharmacology 33 (1994) 1545-1552
62. Sammut S., Bethus I., Goodall G., and Muscat R. Antidepressant reversal of interferon-α-induced anhedonia. Physiol Behav 75 (2002) 765-772
63. Sammut S., Goodall G., and Muscat R. Acute interferon-α administration modulates sucrose consumption in the rat. Psychoneuroendocrinology 26 (2001) 261-272
64. Saphier D., Roerig S.C., Ito C., Vlasak W.R., Farrar G.E., Broyles J.E., et al. Inhibition of neural and neuroendocrine activity by α-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat. Brain Behav Immun 8 (1994) 37-56
65. Saphier D., Welch J.E., and Chuluyan H.E. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat. Eur J Pharmacol 236 (1993) 183-191
66. ®A Interferon alfa-2b recombinant for injection: product information (2002), Becton Dickinson and Company, Kenilworth, NJ. http://patient.cancerconsultants.com/druginserts/Interferon.pdf
67. Segall M.A., and Crnic L.S. An animal model for the behavioural effects of interferon. Behav Neurosci 104 (1990) 612-618
68. Shinozaki K., Ebert O., Suriawinata A., Thung S.N., and Woo S.L. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competentrats. J Virol 79 (2005) 13705-13713
69. Smith A., Tyrell D., Coyle K., and Higgins P. Effects of interferon-alpha on performance in man: a preliminary study. Psychopharmacology 96 (1988) 414-416
70. SPSS for Windows, Rel. 13.0, 2004, Chicago: SPSS Inc.
71. Sudom K., Turrin N.P., Haley S., and Anisman H. Influence of chronic interleukin-2 infusion and stressors on sickness behaviors and neurochemical changes in mice. Neuroimmunomodulation 11 (2004) 341-350
72. Ucar D.A., Tocco R.J., and Kluger M.J. Circadian variation in circulating pyrogen: possible role in resistance to infection. Proc Soc Exp Biol Med 173 (1983) 319-323
73. Verbugge L.M. Sex differences in complaints and diagnoses. J Behav Med 3 (1980) 327-355
74. Wichers M.C., Kenis G., Leue C., Koek G., Robaeys G., and Maes M. Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. Biol Psychiatry 60 (2006) 77-79
75. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 134 (1997) 319-329
76. Yirmiya R., Avitsur R., Donchin O., and Cohen E. Interleukin-1 inhibits sexual behavior in female but not in male rats. Brain Behav Immun 9 (1995) 220-233
77. Zalcman S., Murray L., Dyck D.G., Greenberg A.H., and Nance D.M. Interleukin-2 and -6 induce behavioural-activating effects in mice. Brain Res 811 (1998) 111-121